Award
Delivery Order #SPE2DR26FKUV1
DMS Pharmaceutical Group Awarded Delivery Order for MIRENA 52 MG Systems
Buyer
Defense Logistics Agency
Award Amount
$2,737.40
Ceiling
$2,737.40
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Apr 01, 2026
Identifier
SPE2DR26FKUV1
NAICS
424210
This award represents a delivery order contract under the indefinite delivery vehicle held by DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical products and services. The contract procures MIRENA 52 MG drug delivery systems, which are likely used for medical treatment requiring precise pharmaceutical administration. The delivery order signifies an ongoing relationship within a multi-year pharmaceutical contract, reinforcing DMS Pharmaceutical Group's role as a reliable supplier in government healthcare procurement. The scope includes the acquisition and delivery of these specified drug delivery systems, ensuring availability and support within the set performance timeframe. The contract was awarded following the earlier indefinite delivery vehicle contract, indicating a continuation and fulfillment of specific product requirements within that larger framework. The delivery order covers a short, defined period in early 2026, reflecting a prompt and focused procurement action to meet immediate agency needs. The contract was competitively sourced through the parent IDV, enhancing the government's access to essential pharmaceutical products, though this particular delivery order itself is a direct task under that umbrella. This award contributes to the government's capacity to manage pharmaceutical inventories efficiently and maintain public health readiness.
Description
4571172963!MIRENA 52 MG SYSTEMS